Durable medical equipment (DME) includes long-lasting devices used to help people manage health conditions and improve mobility, such as wheelchairs, hospital beds, and oxygen machines. These items are designed to be reused and are often covered by health insurance. For investors, DME represents a steady market because demand remains consistent as populations age and healthcare needs grow.
oncologymedical
Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.
wound therapymedical
Wound therapy is the range of products, treatments and procedures used to help cuts, ulcers and surgical wounds heal, from basic dressings to advanced devices and biological medicines. Investors care because this is a steady, often growing market driven by aging populations, chronic diseases and hospital practices; product effectiveness, regulatory approval, insurance coverage and adoption by clinicians determine sales and long-term returns. Think of it as the medical “repair kit” and process that prevents problems and speeds recovery.
biomedical servicesmedical
Biomedical services are companies and organizations that provide the technical work behind medical research, testing, and product development — things like lab testing, clinical trial support, data analysis, manufacturing support and regulatory compliance. Investors care because these services act like the backstage crew for healthcare products: steady contracts and regulatory approvals can create predictable revenue, while changes in science, policy or demand can quickly affect growth and profit potential.
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
Investor Conference Call to be held 9:00 a.m. Eastern Time
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2026 financial results on Thursday, May 7, 2026, before the market opens.
The Company will also conduct a conference call for all interested parties on Thursday, May 7, 2026 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ or by calling (855) 669-9658 or (412) 317-0088, replay access code 1097864 through Thursday, May 14, 2026.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing last-mile solutions for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.
